Statements (38)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
beta blocker |
| gptkbp:approvedBy |
1976
|
| gptkbp:ATCCode |
gptkb:C07AB03
|
| gptkbp:brand |
gptkb:Tenormin
|
| gptkbp:CASNumber |
gptkb:29122-68-7
|
| gptkbp:contraindication |
asthma
heart block severe bradycardia |
| gptkbp:discoveredBy |
gptkb:ICI_Pharmaceuticals
|
| gptkbp:eliminationHalfLife |
6-7 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:hasMolecularFormula |
C14H22N2O3
|
| https://www.w3.org/2000/01/rdf-schema#label |
Atenololum
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:meltingPoint |
152-155°C
|
| gptkbp:metabolism |
minimal hepatic
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
2162
2249 |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
dizziness
fatigue bradycardia cold extremities |
| gptkbp:UNII |
50VV3VW0TI
|
| gptkbp:usedFor |
gptkb:arrhythmia
myocardial infarction hypertension angina pectoris |
| gptkbp:bfsParent |
gptkb:ChEMBL1044
gptkb:CHEMBL123 gptkb:CHEMBL1428 gptkb:CHEMBL691 gptkb:CHEMBL1092 gptkb:CHEMBL1401 |
| gptkbp:bfsLayer |
6
|